6051 - 6060 of 8654 Results
Title
Year
-
RESTRICTEDTitle: Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cellsJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 27Start Page: 12858End Page: 12870Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c9nr01277jCitation Count: 55
-
OPENTitle: Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 6Start Page: 650End Page: 653Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.02.026Citation Count: 351
-
OPENTitle: Naturally occurring hyperactive variants of human parkinJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s42003-024-06656-xBest OA location URL: https://doi.org/10.1038/s42003-024-06656-xCitation Count: 0
-
OPENTitle: Integrating Next-Generation Genomic Sequencing and Mass Spectrometry To Estimate Allele-Specific Protein Abundance in Human BrainJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 16Issue #: 9Start Page: 3336End Page: 3347Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.7b00324Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5698003Citation Count: 55
-
OPENTitle: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 69Issue #:Start Page: 102474End Page: 102474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdfCitation Count: 18
-
OPENTitle: Hsp110 mitigates α-synuclein pathology in vivoJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 48Start Page: 24310End Page: 24316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1903268116Best OA location URL: https://www.pnas.org/content/pnas/116/48/24310.full.pdfCitation Count: 53
-
OPENTitle: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 672End Page: 680Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28382Best OA location URL: https://doi.org/10.1002/mds.28382Citation Count: 20
-
OPENTitle: Crohn’s and Parkinson’s Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex VivoJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page: 794End Page: 800Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11481-020-09909-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-020-09909-8.pdfCitation Count: 19
-
RESTRICTEDTitle: Neuropathological findings and in vivo imaging correlates of the red nucleus compared to those of the substantia nigra pars compacta in parkinsonismsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 125Issue #:Start Page: 107043End Page: 107043Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107043Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107043Citation Count: 1
-
OPENTitle: Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s diseaseJournal Name: PeerJPublisher: PeerJVol: 6Issue #:Start Page: e5539End Page: e5539Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7717/peerj.5539Best OA location URL: https://doi.org/10.7717/peerj.5539Citation Count: 19